EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fusidic Acid Reverses Chemoresistance in Breast Cancer via Targeting DDX6 to Downregulate GSK‐3β/β‐Catenin Signaling

Xiaxia Fan iD, Dan Guo, Songtao Li, Jinmiao Tian, Chaotong Zhang, Zhuoyu Li iD

Advanced Science · 2025

DOI: 10.1002/advs.202504680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xiaxia Fan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Chemical Biology and Molecular Engineering of the National Ministry of Education, Institute of Biotechnology, Shanxi University, Ta…. Hauptthemen laut MEDLINE: Glycogen Synthase Kinase 3 beta, Breast Neoplasms, DEAD-box RNA Helicases, Drug Resistance, Neoplasm. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development (R&D) Program of Shanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ABC transporter protein‐mediated drug efflux is a significant contributor to induced resistance in breast cancer (BC). Novel therapies are therefore urgently needed to thwart chemoresistance. Herein, it is demonstrated that fusidic acid (FA) reduces the expression of ABC transporter proteins MRP1, P‐gp, and BCRP, promotes the in vivo accumulation of agents, and exertes chemosensitizing effects. Further, DDX6 is identified as a direct target of FA by DARTS and biotin pull‐down. Mechanistically, the results indicates that FA directly binds to H378 of DDX6, promotes its degradation, and downregulates its downstream p‐GSK‐3β, which in turn enhances the phosphorylation and ubiquitin‐dependent hydrolysis of β‐catenin S33/37/45/T41, blocks pro‐resistance β‐catenin signaling, and further prevents chemoresistance. The inhibitory effect of FA on chemoresistance is blocked following the knockout of DDX6 using CRISPR/Cas9. More importantly, FA also enhances the interaction between DDX6 and HSC70, while it facilitates DDX6 degradation via chaperone‐mediated autophagy (CMA), thereby impairing the GSK‐3β/β‐catenin axis to enhance the efficacy of FA. Consistently, the effect of FA in combating chemoresistance by targeting DDX6 is evident in a xenograft mouse model. These findings reveal a direct protein target and molecular mechanism for FA to reverse chemoresistance, thus supporting the further development of FA as a chemosensitizing agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycogen Synthase Kinase 3 betaBreast NeoplasmsDEAD-box RNA HelicasesDrug Resistance, Neoplasmbeta CateninProto-Oncogene ProteinsHumansFemaleAnimalsMiceSignal TransductionCell Line, TumorDown-RegulationMice, Nude

Stichwörter der Autor:innen

DDX6GSK‐3β/β‐catenin signalingHSC70chemoresistancefusidic acid

Substanzen

Glycogen Synthase Kinase 3 betaDEAD-box RNA Helicasesbeta CateninProto-Oncogene Proteins

Autor:innen und Institutionen

  • Key Laboratory of Chemical Biology and Molecular Engineering of the National Ministry of Education, Institute of Biotechnology, Shanxi University, Taiyuan, 030031, China.

ORCID-Profile: Xiaxia Fan, Zhuoyu Li

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development (R&D) Program of Shanxi Province

Zitieren

APA

Fan, X., Guo, D., Li, S., Tian, J., Zhang, C., & Li, Z. (2025). Fusidic Acid Reverses Chemoresistance in Breast Cancer via Targeting DDX6 to Downregulate GSK‐3β/β‐Catenin Signaling. Advanced Science. https://doi.org/10.1002/advs.202504680

Vancouver

Fan X, Guo D, Li S, Tian J, Zhang C, Li Z. Fusidic Acid Reverses Chemoresistance in Breast Cancer via Targeting DDX6 to Downregulate GSK‐3β/β‐Catenin Signaling. Advanced Science. 2025. doi:10.1002/advs.202504680

BibTeX
@article{Fan2025,
  author = {Fan, Xiaxia and Guo, Dan and Li, Songtao and Tian, Jinmiao and Zhang, Chaotong and Li, Zhuoyu},
  title = {Fusidic Acid Reverses Chemoresistance in Breast Cancer via Targeting DDX6 to Downregulate GSK‐3β/β‐Catenin Signaling},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202504680}
}
Kostenlos starten →